REMI
LIVE

Serial Number

98001768

Owner

Celmatrix Corporation

Attorney

Steven John Hultquist

Filing Date

May 17, 2023

Add to watchlist:

No watchlists yet
View on USPTO

REMI Trademark

Serial Number: 98001768

REMI is a trademark filed by Celmatrix Corporation on May 17, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Celmatrix Corporation (25 trademarks)

c/o Hultquist IP, 510 Meadowmont Village Circle PMB #363
Chapel Hill, NC 27517

Entity Type: 03

REMI INVESTMENT HOLDINGS, LLC (24 trademarks)

2600 PASEO VERDE PARKWAY
HENDERSON, NV 89074

Entity Type: 16

Trademark Details

Filing Date

May 17, 2023

Registration Date

Not Registered

Published for Opposition

March 31, 2026

Goods & Services

antibiotic pharmaceuticals, anti-diabetic pharmaceuticals, antiviral pharmaceuticals, ocular pharmaceuticals, cardiovascular pharmaceuticals, pulmonary pharmaceuticals, bronchodilator pharmaceuticals, analgesic pharmaceuticals, muscle relaxant pharmaceuticals, hyperlipidemia pharmaceuticals, psychotropic pharmaceuticals, decongestant pharmaceuticals, weight loss pharmaceuticals, anticancer pharmaceuticals, antidepressant pharmaceuticals, vaccine pharmaceuticals, antihelmintic pharmaceuticals, antitussive pharmaceuticals, and anticoagulant pharmaceuticals; prescription medicines, namely, prescription pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases and for the treatment of diabetes; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders

telemedicine services; telehealth services in the nature of telemedicine services; medical information services; medical information services provided via the Internet; providing medical information; prescription medicine refill reminder services; online pharmaceutical medication counseling and prescription services in the nature of preparation of prescriptions by pharmacists

Filing History

EXTENSION OF TIME TO OPPOSE RECEIVED
Apr 27, 2026 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 31, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 31, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 25, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 6, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 4, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 4, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 4, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 4, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 24, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 24, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 24, 2025 GNRN
NON-FINAL ACTION E-MAILED
Oct 24, 2025 GNRT
NON-FINAL ACTION WRITTEN
Oct 24, 2025 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 4, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 4, 2025 RCSC
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 16, 2024 ASGN
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 10, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 10, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jun 10, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 16, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 16, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 16, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 16, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 9, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 20, 2023 NWOS
NEW APPLICATION ENTERED
May 20, 2023 NWAP